Politics
Overton’s nomination withdrawal means no clear end for FDA leadership vacuum
The Hill·November 21, 2026·1 min read
The White House abruptly withdrew Heidi Overton as President Trump's nominee to lead the FDA, catching senators by surprise and leaving the agency without stable leadership six months after the former commissioner resigned. Sen. Bill Cassidy (R-La.), chair of the Senate Health committee, expressed concern, and industry observers remain anxious about the ongoing vacuum.
Read at The HillDaily crypto arcade
Read the news, then play it.
Chainshorts turns crypto headlines into a daily game. Catch up in 60 words, then jump into daily lucky draws for a shot at the pot.
